1. known history of ivermectin allergy 2. hypersensitivity to any component of ivermectin or the excipients of the brand to be used. 3. covid-19 pneumonia * diagnosed by the treating physician * identified on a chest x-ray 4. fever or cough present for more than 48 hours. 5. immunoglobulin g (igg) positive against sars-cov-2 by a rapid diagnostic test 8. recent travel history to loa endemic countries (angola, cameroon, central african republic, chad, the democratic republic of the congo, ethiopia, equatorial guinea, gabon, republic of the congo, nigeria, and sudan) 9. current use of quinidine, amiodarone, diltiazem, spironolactone, verapamil, clarithromycin, erythromycin, itraconazole, ketoconazole, cyclosporine, tacrolimus, indinavir, ritonavir, or cobicistat. use of critical drugs such as warfarin.

1. known history of ivermectin allergy 2. hypersensitivity to any component of ivermectin or the excipients of the brand to be used. 3. covid-19 pneumonia * diagnosed by the treating physician * identified on a chest x-ray 4. fever or cough present for more than 48 hours. 5. immunoglobulin g (igg) positive against sars-cov-2 by a rapid diagnostic test 8. recent travel history to loa endemic countries (angola, cameroon, central african republic, chad, the democratic republic of the congo, ethiopia, equatorial guinea, gabon, republic of the congo, nigeria, and sudan) 9. current use of quinidine, amiodarone, diltiazem, spironolactone, verapamil, clarithromycin, erythromycin, itraconazole, ketoconazole, cyclosporine, tacrolimus, indinavir, ritonavir, or cobicistat. use of critical drugs such as warfarin.

known history of ivermectin allergy hypersensitivity to any component of ivermectin or the excipients of the brand to be used. covid-19 pneumonia diagnosed by the treating physician identified on a chest x-ray fever or cough present for more than 48 hours. immunoglobulin g (igg) positive against sars-cov-2 by a rapid diagnostic test 8. recent travel history to loa endemic countries (angola, cameroon, central african republic, chad, the democratic republic of the congo, ethiopia, equatorial guinea, gabon, republic of the congo, nigeria, and sudan) 9. current use of quinidine, amiodarone, diltiazem, spironolactone, verapamil, clarithromycin, erythromycin, itraconazole, ketoconazole, cyclosporine, tacrolimus, indinavir, ritonavir, or cobicistat. use of critical drugs such as warfarin.

known history of ivermectin allergy hypersensitivity to any component of ivermectin or the excipients of the brand to be used. covid-19 pneumonia diagnosed by the treating physician identified on a chest x-ray fever or cough present for more than 48 hours. immunoglobulin g (igg) positive against sars-cov-2 by a rapid diagnostic test 8. recent travel history to loa endemic countries (angola, cameroon, central african republic, chad, the democratic republic of the congo, ethiopia, equatorial guinea, gabon, republic of the congo, nigeria, and sudan) 9. current use of quinidine, amiodarone, diltiazem, spironolactone, verapamil, clarithromycin, erythromycin, itraconazole, ketoconazole, cyclosporine, tacrolimus, indinavir, ritonavir, or cobicistat. use of critical drugs such as warfarin.

1. known history of ivermectin allergy 2. hypersensitivity to any component of ivermectin or the excipients of the brand to be used. 3. covid-19 pneumonia - diagnosed by the treating physician - identified on a chest x-ray 4. fever or cough present for more than 48 hours. 5. immunoglobulin g (igg) positive against sars-cov-2 by a rapid diagnostic test 8. recent travel history to loa endemic countries (angola, cameroon, central african republic, chad, the democratic republic of the congo, ethiopia, equatorial guinea, gabon, republic of the congo, nigeria, and sudan) 9. current use of quinidine, amiodarone, diltiazem, spironolactone, verapamil, clarithromycin, erythromycin, itraconazole, ketoconazole, cyclosporine, tacrolimus, indinavir, ritonavir, or cobicistat. use of critical drugs such as warfarin.

1. known history of ivermectin allergy 2. hypersensitivity to any component of ivermectin or the excipients of the brand to be used. 3. covid-19 pneumonia - diagnosed by the treating physician - identified on a chest x-ray 4. fever or cough present for more than 48 hours. 5. immunoglobulin g (igg) positive against sars-cov-2 by a rapid diagnostic test 8. recent travel history to loa endemic countries (angola, cameroon, central african republic, chad, the democratic republic of the congo, ethiopia, equatorial guinea, gabon, republic of the congo, nigeria, and sudan) 9. current use of quinidine, amiodarone, diltiazem, spironolactone, verapamil, clarithromycin, erythromycin, itraconazole, ketoconazole, cyclosporine, tacrolimus, indinavir, ritonavir, or cobicistat. use of critical drugs such as warfarin.